ResMed Inc. (RSMDF)

SEC filing

ResMed Inc.

RSMDF · CIK 943819

4 · Sep 10, 2026 · Director, Chairman and CEO Farrell Michael J. sold 4,991 shares at $222.44/share ($1.1M); exercised options for 4,991 shares

Director, Chairman and CEO Farrell Michael J. sold 4,991 shares at $222.44/share ($1.1M); exercised options for 4,991 shares

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Graphics and non-inline formats (not embedded below).